Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir

J Gen Virol. 1989 Feb:70 ( Pt 2):375-82. doi: 10.1099/0022-1317-70-2-375.

Abstract

A series of herpes simplex virus isolates were recovered from a bone marrow transplant patient who received prolonged acyclovir therapy for indolent herpes simplex mouth and throat ulceration. Of 14 isolates received 10 were resistant to acyclovir and partially resistant to phosphonoacetic acid. Biochemical characterization revealed that resistance was due to an alteration in the virus DNA polymerase. DNA sequence analysis of the polymerase gene of a plaque-purified resistant virus isolate revealed a single nucleotide change when compared with the sequence of the gene of a plaque-purified sensitive isolate. This single base change resulted in a predicted amino acid substitution of Gly to Ser at residue number 841, a putative functional region of the polymerase.

Publication types

  • Case Reports

MeSH terms

  • Acyclovir / therapeutic use*
  • Adult
  • Base Sequence
  • Bone Marrow / microbiology
  • Bone Marrow Transplantation
  • DNA-Directed DNA Polymerase / genetics*
  • Drug Resistance, Microbial
  • Female
  • Genes, Viral
  • Humans
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / microbiology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / microbiology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Mutation
  • Simplexvirus / drug effects
  • Simplexvirus / enzymology*
  • Simplexvirus / genetics
  • Simplexvirus / isolation & purification
  • Stomatitis, Herpetic / drug therapy
  • Stomatitis, Herpetic / microbiology

Substances

  • DNA-Directed DNA Polymerase
  • Acyclovir